These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32178819)

  • 1. Decoding cancer cell death-driven immune cell recruitment: An in vivo method for site-of-vaccination analyses.
    Fang S; Agostinis P; Salven P; Garg AD
    Methods Enzymol; 2020; 636():185-207. PubMed ID: 32178819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenic Cell Death Amplified by Co-localized Adjuvant Delivery for Cancer Immunotherapy.
    Fan Y; Kuai R; Xu Y; Ochyl LJ; Irvine DJ; Moon JJ
    Nano Lett; 2017 Dec; 17(12):7387-7393. PubMed ID: 29144754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity.
    Efimova I; Catanzaro E; Van der Meeren L; Turubanova VD; Hammad H; Mishchenko TA; Vedunova MV; Fimognari C; Bachert C; Coppieters F; Lefever S; Skirtach AG; Krysko O; Krysko DV
    J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33188036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell death and immunity in cancer: From danger signals to mimicry of pathogen defense responses.
    Garg AD; Agostinis P
    Immunol Rev; 2017 Nov; 280(1):126-148. PubMed ID: 29027218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to anticancer vaccination effect is controlled by a cancer cell-autonomous phenotype that disrupts immunogenic phagocytic removal.
    Garg AD; Elsen S; Krysko DV; Vandenabeele P; de Witte P; Agostinis P
    Oncotarget; 2015 Sep; 6(29):26841-60. PubMed ID: 26314964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell-driven rejection of high-grade glioma.
    Garg AD; Vandenberk L; Koks C; Verschuere T; Boon L; Van Gool SW; Agostinis P
    Sci Transl Med; 2016 Mar; 8(328):328ra27. PubMed ID: 26936504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenic Apoptosis as a Novel Tool for Anticancer Vaccine Development.
    Montico B; Nigro A; Casolaro V; Dal Col J
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29462947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Necroptosis in Immuno-Oncology and Cancer Immunotherapy.
    Sprooten J; De Wijngaert P; Vanmeerbeerk I; Martin S; Vangheluwe P; Schlenner S; Krysko DV; Parys JB; Bultynck G; Vandenabeele P; Garg AD
    Cells; 2020 Aug; 9(8):. PubMed ID: 32752206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines.
    Ruffini PA; Neelapu SS; Kwak LW; Biragyn A
    Haematologica; 2002 Sep; 87(9):989-1001. PubMed ID: 12217812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A vaccine for photodynamic immunogenic cell death: tumor cell caged by cellular disulfide-thiol exchange for immunotherapy.
    Wen Y; Liu Y; Guo F; Han Y; Qiu Q; Li Y; Dong H; Ren T; Li Y
    Biomater Sci; 2021 Feb; 9(3):973-984. PubMed ID: 33300512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type I interferons and dendritic cells in cancer immunotherapy.
    Sprooten J; Agostinis P; Garg AD
    Int Rev Cell Mol Biol; 2019; 348():217-262. PubMed ID: 31810554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune adjuvants as critical guides directing immunity triggered by therapeutic cancer vaccines.
    Schijns V; Tartour E; Michalek J; Stathopoulos A; Dobrovolskienė NT; Strioga MM
    Cytotherapy; 2014 Apr; 16(4):427-39. PubMed ID: 24280238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of immunogenic cell death in gastrointestinal cancer immunotherapy (Review).
    Songjang W; Nensat C; Pongcharoen S; Jiraviriyakul A
    Biomed Rep; 2021 Oct; 15(4):86. PubMed ID: 34512974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective cancer immunotherapy by natural mouse conventional type-1 dendritic cells bearing dead tumor antigen.
    Wculek SK; Amores-Iniesta J; Conde-Garrosa R; Khouili SC; Melero I; Sancho D
    J Immunother Cancer; 2019 Apr; 7(1):100. PubMed ID: 30961656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inefficacy of therapeutic cancer vaccines and proposed improvements. Casus of prostate cancer.
    Jacobs JJ; Snackey C; Geldof AA; Characiejus D; Van Moorselaar RJ; Den Otter W
    Anticancer Res; 2014 Jun; 34(6):2689-700. PubMed ID: 24922629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenic Cell Death-Based Cancer Vaccines.
    Jin MZ; Wang XP
    Front Immunol; 2021; 12():697964. PubMed ID: 34135914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenic Cell Death and Role of Nanomaterials Serving as Therapeutic Vaccine for Personalized Cancer Immunotherapy.
    Catanzaro E; Feron O; Skirtach AG; Krysko DV
    Front Immunol; 2022; 13():925290. PubMed ID: 35844506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dying to Be Noticed: Epigenetic Regulation of Immunogenic Cell Death for Cancer Immunotherapy.
    Cruickshank B; Giacomantonio M; Marcato P; McFarland S; Pol J; Gujar S
    Front Immunol; 2018; 9():654. PubMed ID: 29666625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanomicelle protects the immune activation effects of Paclitaxel and sensitizes tumors to anti-PD-1 Immunotherapy.
    Yang Q; Shi G; Chen X; Lin Y; Cheng L; Jiang Q; Yan X; Jiang M; Li Y; Zhang H; Wang H; Wang Y; Wang Q; Zhang Y; Liu Y; Su X; Dai L; Tang M; Li J; Zhang L; Qian Z; Yu D; Deng H
    Theranostics; 2020; 10(18):8382-8399. PubMed ID: 32724476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Dendritic Cell-Based Vaccination Protocol to Stimulate Immunosurveillance of Aggressive Cancers.
    Nigro A; Montico B; Casolaro V; Dal Col J
    Methods Mol Biol; 2019; 1884():317-333. PubMed ID: 30465213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.